Interestingly, a recent clinical study found that elevated GPC4 levels in the CSF and serum of Parkinson’s disease patients correlated with worse cognitive function [63], raising the possibility that soluble GPC4 may also be involved in synucleinopathies. This evidence concerns the gene GPC4 and synucleinopathy.